Sep 4, 2026 08:00AM
Aug 20, 2026 07:06AM
Aug 20, 2026 07:05AM
Aug 20, 2026 07:00AM
Aug 20, 2026 07:00AM
Aug 20, 2026 06:57AM
Aug 17, 2026 08:04AM UroGen files NDA with FDA for bladder cancer drug UGN-103
Aug 17, 2026 08:00AM
Aug 5, 2026 08:00AM
Jul 15, 2026 08:00AM
Jul 15, 2026 08:00AM
Jul 9, 2026 06:49AM
Jul 8, 2026 08:02AM
Jul 8, 2026 08:00AM UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
Jun 5, 2026 08:00AM
Jun 3, 2026 06:53AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 13, 2026 08:02AM UroGen reports 64.5% three-year response rate for ZUSDURI bladder cancer drug
May 13, 2026 08:00AM
May 11, 2026 07:12AM
May 6, 2026 08:00AM
Mar 30, 2026 08:05AM
Mar 30, 2026 08:00AM
Mar 6, 2026 04:10PM
Mar 2, 2026 08:04AM UroGen launches ZUSDURI as revenue rises 21% in 2025
Mar 2, 2026 08:00AM
Feb 27, 2026 08:30AM
Feb 24, 2026 04:05PM
Feb 23, 2026 08:00AM
Feb 4, 2026 08:00AM
Jan 5, 2026 08:00AM
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 5, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 6, 2025 07:58AM
Nov 6, 2025 07:58AM
Nov 4, 2025 08:00AM
Oct 30, 2025 08:00AM
Oct 27, 2025 08:00AM Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026
Oct 24, 2025 08:29AM
Oct 2, 2025 08:02AM
Oct 2, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 21, 2025 08:00AM
Aug 19, 2025 06:18AM
Aug 7, 2025 08:00AM UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
Aug 5, 2025 08:00AM

330,652 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All